Search Results 251-260 of 17048 for nivolumab
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
In-home Versus In-Clinic Subcutaneous Nivolumab Administration Through Connected And Remote Cancer CARE Beyond Walls. Jacksonville, Fla. The purpose of this ...
Its primary objective is to conduct a prospective observational study on the efficacy of using MP-TSCPC to treat glaucoma patients. A Study to Compare Nivolumab ...
... Nivolumab in Subjects With Locally Advanced or Metastatic Tumors Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. The purpose of this study is to ...
IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the ...
The Food and Drug Administration approved the combination of chemotherapy with nivolumab, an immunotherapeutic drug, in metastatic gastric adenocarcinoma.
SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of life.
The purpose of this study is to characterize the safety and tolerability of combined treatment with mogamulizumab and nivolumab, and also determine the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!